The Academy’s Ad Hoc Task Force on COVID-19 is monitoring pandemic developments daily, assessing the impact on practices, and providing guidance most relevant to dermatologists. The most current information is being posted to these pages as we have it. Check back for updates.
The AADA is monitoring legislative and regulatory developments related to COVID-19 as the government seeks to limit the spread of the virus and its impact on the nation’s economy. Below you will find information on the most recent actions taken by the federal and state governments to address the COVID-19 outbreak.
Access the Academy's advocacy efforts on behalf of dermatology related to the emergency.
Review federal legislation, including both passed and pending legislation.
Learn about how CMS has relaxed and revised regulatory requirements during the emergency.
Access information about changes at the state level.
Navigate the Coronavirus Resource Center
All content solely developed by the American Academy of Dermatology